{"id":977929,"date":"2026-07-01T15:55:11","date_gmt":"2026-07-01T19:55:11","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/mdln-alert-hbss-probes-medline-mdln-after-reports-reveal-undisclosed-manufacturing-violations-and-failed-contamination-investigations\/"},"modified":"2026-07-01T15:55:11","modified_gmt":"2026-07-01T19:55:11","slug":"mdln-alert-hbss-probes-medline-mdln-after-reports-reveal-undisclosed-manufacturing-violations-and-failed-contamination-investigations","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/mdln-alert-hbss-probes-medline-mdln-after-reports-reveal-undisclosed-manufacturing-violations-and-failed-contamination-investigations\/","title":{"rendered":"MDLN ALERT: HBSS Probes Medline (MDLN) After Reports Reveal Undisclosed Manufacturing Violations and Failed Contamination Investigations"},"content":{"rendered":"<div class=\"mw_release\">\n<p>SAN FRANCISCO, July  01, 2026  (GLOBE NEWSWIRE) &#8212; National shareholder rights firm Hagens Berman Sobol Shapiro (HBSS) has launched an investigation into Medline Inc. <strong>(NASDAQ: MDLN)<\/strong> focusing on whether the company may have misled investors regarding the adequacy of its manufacturing quality controls and compliance with FDA safety standards.<\/p>\n<p align=\"center\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JFOW7JA_pdM-mrS5603jF60S6nbgdtx1Lcb9jl99FCgMr3Oa-xOEpuxvE8TGPEZNJlkLt7F0aong8nzGUdV-COKymWOavYMR1ubSCqUgzAAahuGFStUxKUbZCkIeB-y_cKP9z6uyBRMq4tew5r6bqgsxISQKAI9IAyUbyJf-hsw=\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong>SUBMIT YOUR MDLN INVESTMENT LOSSES TO HBSS NOW<\/strong><br \/>\n        <\/a>\n      <\/p>\n<p>The firm is looking into whether Medline concealed systemic lapses in its contamination protocols\u2014specifically failures to investigate microbial incidents and batch discrepancies\u2014that prompted regulatory scrutiny and triggered a significant decline in the company\u2019s share price.<\/p>\n<p>\n        <strong>Visit:<\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MTpz8tyddoAAQ2aZZ7S5qUZ7-D2r7Q_VQLygTrQvfXjoBaVX6YAz1pGuhoGQ1TQHe6xQ1yxoNdKaHUD0-OKz7VVI2y6DB5eVCNInMg4L30AKbM4AF8Cbmtq8byGvH9wwgw10nrC_tP0_YZYU5CcbJw==\" rel=\"nofollow\" target=\"_blank\">www.hbsslaw.com\/investor-fraud\/mdln<\/a><br \/>\n        <br \/>\n        <strong>Contact the Firm Now:<\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5PcBkyaYEXuDjpADPQq8LaJTFSFTQRsIfMb_dihX1SeTQo14QgdH30JkhU3HU7II6z3-eQq0bFJU57NL4J-CyGoKF4UuVjLj0mWnAJacWsM=\" rel=\"nofollow\" target=\"_blank\">MDLN@hbsslaw.com<\/a><br \/>\n        <br \/>\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0<strong>844-916-0895<\/strong><\/p>\n<p>\n        <strong>Medline Inc. (MDLN) Investigation:<\/strong>\n      <\/p>\n<p>Since Medline went public in December 2025, it has assured investors that \u201c[w]e are committed to delivering products of the highest standard, which is reflected by our robust quality team of over 2,400 employees[]\u201d and \u201c[t]heir expertise ensures that every product bearing the Medline brand meets both our rigorous quality standards and our customers\u2019 expectations[.]\u201d<\/p>\n<p>The effectiveness of the company\u2019s quality team first came into question on June 2, 2026, when the FDA published its May 28 warning letter addressed to CEO Boyle. The FDA recited specific CGMP violations and said \u201cyour drug products are adulterated[.]\u201d<\/p>\n<p>The FDA highlighted the following deficiencies:<\/p>\n<ul type=\"disc\">\n<li>\u201cBetween June 2, 2023 and August 27, 2025, your firm isolated objectionable microorganisms [\u2026] from finished drug product samples on approximately nine occasions[;]\u201d<\/li>\n<li>\u201cYou also recovered [the objectionable microorganisms] in at least five samples taken from your manufacturing environment since January 2025[;]\u201d<\/li>\n<li>\u201cYou failed to adequately investigate and implement corrective actions and preventative actions (CAPA) to determine root causes and prevent recurrence of these repeated contamination incidents[;]\u201d and<\/li>\n<li>\u201cThis issue was cited on the previous Form FDA 483 issued to your firm in January 2025 and subsequently discussed during the most recent regulatory meeting held with your firm in May 2025.\u201d<\/li>\n<\/ul>\n<p>Investors also learned for the first time the next day that, as a result of the quality problems, Medline had shut down certain problematic facilities last October.<\/p>\n<p>The market\u2019s significantly negative reaction to these revelations erased about $2.2 billion from Medline\u2019s market capitalization.<\/p>\n<p>\u201cWe\u2019re focused on whether Medline concealed from investors the serious concerns raised by the FDA,\u201d said <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jmDXehGkZl_ufYsPHOTGxVfruszqiuSGCvShpHcvOgesLpxjC5nyTNL46pM8ZRyruPGbW4CGEdMk947_rDeDNnswRQopAdDimt7n3B7J5HVlK_53fPsMj1gjUdsed9bO\" rel=\"nofollow\" target=\"_blank\"><strong>Reed Kathrein<\/strong><\/a>, the Hagens Berman partner leading the firm\u2019s investigation.<\/p>\n<p>If you invested in Medline and have substantial losses, or have knowledge that may assist the firm\u2019s investigation, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jp6x8tHFXxw98P2GVsPtIfQwWq59QF6xdde90A5dS7URm1_yu211e4qDvOqX70tF9k5jssjSfdXg_R_N4opgohrW3aXomOlty8IJL0VvTQdmef6B9l98PEj3uFXh5kUL\" rel=\"nofollow\" target=\"_blank\"><strong>submit your losses now<\/strong><\/a> \u00bb<\/p>\n<p>If you\u2019d like more information and answers to other frequently asked questions about the Medline case and the firm\u2019s investigation, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=KkBqKVnkqbdXIcFpuvDdNRum7v-lpAD9ztsjDI_Xkdv5bZ-AGdGpTYmyFK71VQkXmC44iR66uItOcz6cj539Iws2BjA4QsJih2CfCDnjw77IC0dBOqICjBgbj1t6WNqduQZOJ3zKROjS7APjnR0ASg==\" rel=\"nofollow\" target=\"_blank\"><strong>read more<\/strong><\/a> \u00bb<\/p>\n<p>\n        <strong>Whistleblowers: <\/strong>Persons with non-public information regarding Medline should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at <strong>844-916-0895<\/strong> or email <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5PcBkyaYEXuDjpADPQq8LfbEFqFlC-xXIU6KenTC8aJn4pWXDP1AKMIPVVvhxWFSVxjz8CnpjSHmYzDiK0Ku081MErowVudd7da-zTOxm50=\" rel=\"nofollow\" target=\"_blank\">MDLN@hbsslaw.com<\/a>.<\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=aTvDDym-H7erjnwxclRPECAdjJufxXnNxOBHtDWRV7un_4Uwa_PYpBh6Iwj96NZ9NZ-IbtBs6SHw-Z-tLSD2zQ_sq6YRlzS2s_1hWCaAyhQ=\" rel=\"nofollow\" target=\"_blank\">About Hagens Berman<\/a><br \/>\n        <br \/>Hagens Berman is a global plaintiffs\u2019 rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman\u2019s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=oCLCJ37ypNSbRzJLxihxCpaE2138UWPE-phqaJB-AvG_XDD0u3PIu1qPIYOvIxGXP7kL-StU9QPFCWxuU2Drrw==\" rel=\"nofollow\" target=\"_blank\">hbsslaw.com<\/a>. Follow the firm for updates and news at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=39MXdPHx4uqHB4eYHCbfbuVJP1y9oJ3-UYTcIq3X3Irjz7SC-uAFjROcHnxg9wHNox4IguMSCuCbYRemtnR9D2nTId-OH_4UkoPD-jQppyewnTGX-w4NqZ_D1xgNI3yG\" rel=\"nofollow\" target=\"_blank\">@ClassActionLaw<\/a>.\u00a0<\/p>\n<p>Attorney Advertising. Prior results do not guarantee a similar outcome in any future case.<\/p>\n<p>\n        <u>Contact:<\/u><br \/>\n        <br \/>Reed Kathrein, 844-916-0895<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1NTg0NSM3Njg3NzIzIzIwMTg1MzI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZTNiMjgyNzUtNGFlYS00YWM5LWI5MzUtMjg0MWRjYTFlMzk0LTEwMzAxMDUtMjAyNi0wNy0wMS1lbg==\/tiny\/Hagens-Berman-Sobol-Shapiro-LL.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN FRANCISCO, July 01, 2026 (GLOBE NEWSWIRE) &#8212; National shareholder rights firm Hagens Berman Sobol Shapiro (HBSS) has launched an investigation into Medline Inc. (NASDAQ: MDLN) focusing on whether the company may have misled investors regarding the adequacy of its manufacturing quality controls and compliance with FDA safety standards. SUBMIT YOUR MDLN INVESTMENT LOSSES TO HBSS NOW The firm is looking into whether Medline concealed systemic lapses in its contamination protocols\u2014specifically failures to investigate microbial incidents and batch discrepancies\u2014that prompted regulatory scrutiny and triggered a significant decline in the company\u2019s share price. Visit: www.hbsslaw.com\/investor-fraud\/mdln Contact the Firm Now: MDLN@hbsslaw.com \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0844-916-0895 Medline &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mdln-alert-hbss-probes-medline-mdln-after-reports-reveal-undisclosed-manufacturing-violations-and-failed-contamination-investigations\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;MDLN ALERT: HBSS Probes Medline (MDLN) After Reports Reveal Undisclosed Manufacturing Violations and Failed Contamination Investigations&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-977929","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>MDLN ALERT: HBSS Probes Medline (MDLN) After Reports Reveal Undisclosed Manufacturing Violations and Failed Contamination Investigations - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mdln-alert-hbss-probes-medline-mdln-after-reports-reveal-undisclosed-manufacturing-violations-and-failed-contamination-investigations\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MDLN ALERT: HBSS Probes Medline (MDLN) After Reports Reveal Undisclosed Manufacturing Violations and Failed Contamination Investigations - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN FRANCISCO, July 01, 2026 (GLOBE NEWSWIRE) &#8212; National shareholder rights firm Hagens Berman Sobol Shapiro (HBSS) has launched an investigation into Medline Inc. (NASDAQ: MDLN) focusing on whether the company may have misled investors regarding the adequacy of its manufacturing quality controls and compliance with FDA safety standards. SUBMIT YOUR MDLN INVESTMENT LOSSES TO HBSS NOW The firm is looking into whether Medline concealed systemic lapses in its contamination protocols\u2014specifically failures to investigate microbial incidents and batch discrepancies\u2014that prompted regulatory scrutiny and triggered a significant decline in the company\u2019s share price. Visit: www.hbsslaw.com\/investor-fraud\/mdln Contact the Firm Now: MDLN@hbsslaw.com \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0844-916-0895 Medline &hellip; Continue reading &quot;MDLN ALERT: HBSS Probes Medline (MDLN) After Reports Reveal Undisclosed Manufacturing Violations and Failed Contamination Investigations&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/mdln-alert-hbss-probes-medline-mdln-after-reports-reveal-undisclosed-manufacturing-violations-and-failed-contamination-investigations\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-01T19:55:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1NTg0NSM3Njg3NzIzIzIwMTg1MzI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mdln-alert-hbss-probes-medline-mdln-after-reports-reveal-undisclosed-manufacturing-violations-and-failed-contamination-investigations\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mdln-alert-hbss-probes-medline-mdln-after-reports-reveal-undisclosed-manufacturing-violations-and-failed-contamination-investigations\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"MDLN ALERT: HBSS Probes Medline (MDLN) After Reports Reveal Undisclosed Manufacturing Violations and Failed Contamination Investigations\",\"datePublished\":\"2026-07-01T19:55:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mdln-alert-hbss-probes-medline-mdln-after-reports-reveal-undisclosed-manufacturing-violations-and-failed-contamination-investigations\\\/\"},\"wordCount\":606,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mdln-alert-hbss-probes-medline-mdln-after-reports-reveal-undisclosed-manufacturing-violations-and-failed-contamination-investigations\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc1NTg0NSM3Njg3NzIzIzIwMTg1MzI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mdln-alert-hbss-probes-medline-mdln-after-reports-reveal-undisclosed-manufacturing-violations-and-failed-contamination-investigations\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mdln-alert-hbss-probes-medline-mdln-after-reports-reveal-undisclosed-manufacturing-violations-and-failed-contamination-investigations\\\/\",\"name\":\"MDLN ALERT: HBSS Probes Medline (MDLN) After Reports Reveal Undisclosed Manufacturing Violations and Failed Contamination Investigations - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mdln-alert-hbss-probes-medline-mdln-after-reports-reveal-undisclosed-manufacturing-violations-and-failed-contamination-investigations\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mdln-alert-hbss-probes-medline-mdln-after-reports-reveal-undisclosed-manufacturing-violations-and-failed-contamination-investigations\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc1NTg0NSM3Njg3NzIzIzIwMTg1MzI=\",\"datePublished\":\"2026-07-01T19:55:11+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mdln-alert-hbss-probes-medline-mdln-after-reports-reveal-undisclosed-manufacturing-violations-and-failed-contamination-investigations\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mdln-alert-hbss-probes-medline-mdln-after-reports-reveal-undisclosed-manufacturing-violations-and-failed-contamination-investigations\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mdln-alert-hbss-probes-medline-mdln-after-reports-reveal-undisclosed-manufacturing-violations-and-failed-contamination-investigations\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc1NTg0NSM3Njg3NzIzIzIwMTg1MzI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc1NTg0NSM3Njg3NzIzIzIwMTg1MzI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mdln-alert-hbss-probes-medline-mdln-after-reports-reveal-undisclosed-manufacturing-violations-and-failed-contamination-investigations\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MDLN ALERT: HBSS Probes Medline (MDLN) After Reports Reveal Undisclosed Manufacturing Violations and Failed Contamination Investigations\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MDLN ALERT: HBSS Probes Medline (MDLN) After Reports Reveal Undisclosed Manufacturing Violations and Failed Contamination Investigations - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/mdln-alert-hbss-probes-medline-mdln-after-reports-reveal-undisclosed-manufacturing-violations-and-failed-contamination-investigations\/","og_locale":"en_US","og_type":"article","og_title":"MDLN ALERT: HBSS Probes Medline (MDLN) After Reports Reveal Undisclosed Manufacturing Violations and Failed Contamination Investigations - Market Newsdesk","og_description":"SAN FRANCISCO, July 01, 2026 (GLOBE NEWSWIRE) &#8212; National shareholder rights firm Hagens Berman Sobol Shapiro (HBSS) has launched an investigation into Medline Inc. (NASDAQ: MDLN) focusing on whether the company may have misled investors regarding the adequacy of its manufacturing quality controls and compliance with FDA safety standards. SUBMIT YOUR MDLN INVESTMENT LOSSES TO HBSS NOW The firm is looking into whether Medline concealed systemic lapses in its contamination protocols\u2014specifically failures to investigate microbial incidents and batch discrepancies\u2014that prompted regulatory scrutiny and triggered a significant decline in the company\u2019s share price. Visit: www.hbsslaw.com\/investor-fraud\/mdln Contact the Firm Now: MDLN@hbsslaw.com \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0844-916-0895 Medline &hellip; Continue reading \"MDLN ALERT: HBSS Probes Medline (MDLN) After Reports Reveal Undisclosed Manufacturing Violations and Failed Contamination Investigations\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/mdln-alert-hbss-probes-medline-mdln-after-reports-reveal-undisclosed-manufacturing-violations-and-failed-contamination-investigations\/","og_site_name":"Market Newsdesk","article_published_time":"2026-07-01T19:55:11+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1NTg0NSM3Njg3NzIzIzIwMTg1MzI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mdln-alert-hbss-probes-medline-mdln-after-reports-reveal-undisclosed-manufacturing-violations-and-failed-contamination-investigations\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mdln-alert-hbss-probes-medline-mdln-after-reports-reveal-undisclosed-manufacturing-violations-and-failed-contamination-investigations\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"MDLN ALERT: HBSS Probes Medline (MDLN) After Reports Reveal Undisclosed Manufacturing Violations and Failed Contamination Investigations","datePublished":"2026-07-01T19:55:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mdln-alert-hbss-probes-medline-mdln-after-reports-reveal-undisclosed-manufacturing-violations-and-failed-contamination-investigations\/"},"wordCount":606,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mdln-alert-hbss-probes-medline-mdln-after-reports-reveal-undisclosed-manufacturing-violations-and-failed-contamination-investigations\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1NTg0NSM3Njg3NzIzIzIwMTg1MzI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mdln-alert-hbss-probes-medline-mdln-after-reports-reveal-undisclosed-manufacturing-violations-and-failed-contamination-investigations\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/mdln-alert-hbss-probes-medline-mdln-after-reports-reveal-undisclosed-manufacturing-violations-and-failed-contamination-investigations\/","name":"MDLN ALERT: HBSS Probes Medline (MDLN) After Reports Reveal Undisclosed Manufacturing Violations and Failed Contamination Investigations - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mdln-alert-hbss-probes-medline-mdln-after-reports-reveal-undisclosed-manufacturing-violations-and-failed-contamination-investigations\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mdln-alert-hbss-probes-medline-mdln-after-reports-reveal-undisclosed-manufacturing-violations-and-failed-contamination-investigations\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1NTg0NSM3Njg3NzIzIzIwMTg1MzI=","datePublished":"2026-07-01T19:55:11+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mdln-alert-hbss-probes-medline-mdln-after-reports-reveal-undisclosed-manufacturing-violations-and-failed-contamination-investigations\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/mdln-alert-hbss-probes-medline-mdln-after-reports-reveal-undisclosed-manufacturing-violations-and-failed-contamination-investigations\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mdln-alert-hbss-probes-medline-mdln-after-reports-reveal-undisclosed-manufacturing-violations-and-failed-contamination-investigations\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1NTg0NSM3Njg3NzIzIzIwMTg1MzI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1NTg0NSM3Njg3NzIzIzIwMTg1MzI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mdln-alert-hbss-probes-medline-mdln-after-reports-reveal-undisclosed-manufacturing-violations-and-failed-contamination-investigations\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"MDLN ALERT: HBSS Probes Medline (MDLN) After Reports Reveal Undisclosed Manufacturing Violations and Failed Contamination Investigations"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/977929","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=977929"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/977929\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=977929"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=977929"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=977929"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}